Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.
Press releases published on June 11, 2025
Chiesi Group ingår ett globalt licensavtal med Key2Brain AB för utveckling av terapier som passerar blod-hjärnbarriären för behandling av lysosomala upplagringssjukdomar
GlobeNewswire
·
June 11, 2025
Samarbetet kommer att utnyttja Key2Brains teknik för att ta fram enzymersättningsbehandlingar som passerar blod-hjärnbarriären för lysosomala upplagringssjukdomar Avtalet bygger på ett partnerskap som inleddes 2022 och stödjer fortsatt utveckling som drivs …
Chiesi Group sigla un accordo di licenza mondiale con Key2Brain AB per promuovere terapie che attraversano la barriera ematoencefalica per le malattie da accumulo lisosomiale
GlobeNewswire
·
June 11, 2025
La collaborazione sfrutterà la tecnologia di Key2Brain per sviluppare terapie enzimatiche sostitutive in grado di attraversare la barriera ematoencefalica per le malattie da accumulo lisosomiale L'accordo si basa su una partnership avviata nel 2022, a …
SmartVascular™ Test: Revolutionizing Vascular Risk Assessment Nationwide
GlobeNewswire
·
June 11, 2025
IRVINE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, proudly announces its SmartVascular Dx™ (SVDx) test (formally …
Global Electronic Health Record Market is Projected to Reach ~USD 54 Billion by 2032 | DelveInsight
GlobeNewswire
·
June 11, 2025
New York, USA, June 11, 2025 (GLOBE NEWSWIRE) -- Global Electronic Health Record Market is Projected to Reach ~USD 54 Billion by 2032 | DelveInsight The electronic health records market is experiencing robust growth, primarily driven by the increasing …
KFSHRC First in the Middle East to Implant AI-Powered Brain-Sensing Device for Treating Neurological Disorders
GlobeNewswire
·
June 11, 2025
RIYADH, Saudi Arabia, June 11, 2025 (GLOBE NEWSWIRE) -- In a landmark medical achievement, King Faisal Specialist Hospital …
ONWARD Medical Announces Results of its Annual General Meeting of Shareholders
GlobeNewswire
·
June 11, 2025
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Shareholders approve all proposed resolutions EINDHOVEN, The Netherlands, June 11, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical …
ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025
GlobeNewswire
·
June 11, 2025
ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025 NANTES, France, June 11, 6:30 PM – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), announces the cancellation of the convening of the mixed General Meeting initially …
AJOURNEMENT DE L’ASSEMBLÉE GÉNÉRALE INITIALEMENT CONVOQUEE POUR LE 25 JUIN 2025
GlobeNewswire
·
June 11, 2025
AJOURNEMENT DE L’ASSEMBLÉE GÉNÉRALE INITIALEMENT CONVOQUEE POUR LE 25 JUIN 2025 NANTES, France, 11 juin 2025, 18 heures 30 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), annonce l'annulation de la convocation à l'Assemblée Générale mixte …
WellSpan Provider Network expands robust network of care
GlobeNewswire
·
June 11, 2025
York, Pa., June 11, 2025 (GLOBE NEWSWIRE) -- WellSpan Health is pleased to announce the expansion of its WellSpan Provider Network (WPN) this summer with key providers and practices across the region joining the network. This ensures convenient access for …
Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders
GlobeNewswire
·
June 11, 2025
CINCINNATI, Ohio, June 11, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men’s health …
Centre for Neuro Skills Unveils New Website Design to Better Serve Brain Injury Patients and Their Families
GlobeNewswire
·
June 11, 2025
BAKERSFIELD, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Centre for Neuro Skills (CNS), a leader in traumatic brain injury and stroke rehabilitation services, today announced the launch of its completely redesigned website at www.neuroskills.com. The …
The Carlton at the Lake earns prestigious Enhanced Respiratory Care Accreditation
GlobeNewswire
·
June 11, 2025
Chicago, IL, June 11, 2025 (GLOBE NEWSWIRE) -- The Physician-Patient Alliance for Health …
ACHC and BOC Partner to Support DMEPOS Suppliers Amid Market Changes
GlobeNewswire
·
June 11, 2025
CARY, N.C., June 11, 2025 (GLOBE NEWSWIRE) -- In response to recent regulatory developments, the Accreditation Commission for Health Care (ACHC) and the Board of Certification/Accreditation (BOC) have established a strategic partnership to support DMEPOS …
CLSI partners with LymeX Diagnostics Prize to support Phase 4 team advancing Lyme disease diagnostics
GlobeNewswire
·
June 11, 2025
MALVERN, Pa., June 11, 2025 (GLOBE NEWSWIRE) -- Clinical …
Gapin Institute and Bauman Medical Announce Strategic Partnership – “Peak Launch: Personalized Longevity and Hair Optimization—powered by Gapin Institute for Bauman Medical”
GlobeNewswire
·
June 11, 2025
BOCA RATON, Fla. and SARASOTA, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- The Gapin Institute for Precision Medicine, a global leader in longevity, and Bauman Medical, a global leader in hair restoration and scalp health, are proud to announce the launch of a …
Cabaletta Bio Announces Pricing of Public Offering of Securities
GlobeNewswire
·
June 11, 2025
PHILADELPHIA, June 11, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically …
PESG Research Update: PolyPid SHIELD’s II Delivers Transformative Phase 3 Topline Results - Paradigm Shift in Surgical Infection Prevention
GlobeNewswire
·
June 11, 2025
On June 9th, PolyPid Ltd.* announced landmark topline results from its pivotal SHIELD II Phase 3 trial, demonstrating that D-PLEX100 achieved statistically significant reductions across all primary and secondary endpoints in preventing surgical site …
Wandercraft announces Series D Round, bringing $75M in total funding secured for global acceleration of AI-powered robotics
GlobeNewswire
·
June 11, 2025
Clinical progress, industrial partnerships, and global recognition drive momentum in rehabilitation, personal mobility, and humanoid robotics. New agreement with Renault Group accelerates commercialization and advances Wandercraft’s global robotics …
Capricor Therapeutics Announces Key Regulatory Updates for its Duchenne Muscular Dystrophy Program
GlobeNewswire
·
June 11, 2025
U.S. FDA successfully completed Pre-License Inspection; Company expects facility will meet all requirements to support licensure Advisory Committee meeting scheduled for July 30, 2025 Mid-cycle meeting recently completed with no significant issues or major …
Moleculin Participates in Virtual Investor “What This Means” Segment
GlobeNewswire
·
June 11, 2025
Globally recognized Oncology Key Opinion Leader, Brian Andrew Van Tine, MD, PhD, discusses the positive topline results from the U.S. Phase 1B/2 clinical trial evaluating Annamycin for the treatment of Soft Tissue Sarcoma Lung Metastases (MB-107) Watch the …